Back to search

Article

Differential expression of RSK4 transcript isoforms in cancer and its clinical relevance

2022-10-05

Abstract excerpt

RSK4 belongs to the p90 Ribosomal S6 Kinase family which lies downstream of the MAPK pathway. While we previously revealed this kinase to be a therapeutic target in lung and bladder cancers, there is conflicting evidence for its wider role in other cancer types. Indeed, RSK4 was instead suggested to be a tumour suppressor in colorectal and gastric cancers, and reports of its role in breast malignancies are contrad...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
e6124f2c-2064-5a38-998a-033c1a66fbd8
DOI
10.1101/2022.10.03.510581
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Differential expression of RSK4 transcript isoforms in cancer and its clinical relevanceDOI 10.1101/2022.10.03.510581
Select a neighboring publication to make it the new centre.